Repurposing Drugs for Cancer Treatment

Once you put the patient in this state of nutritional ketosis,

it opens up a whole array,

a new array of drugs that may have been thrown out, not worked.

That's called the whole field of repurposing drugs now.

But once the body is in this new physiological state,

things that were thought to be ineffective become super effective.

So again, that's a whole new field that will open

as the result once this information gets out more.

And you mentioned imbendazole in your talk as well.

Does that have a glutamine blocking aspect to it as well?

Yes, that's in our paper also.

That's another interesting thing.

Parasite medications.

I don't know about ivermectin because there was a lot of political stuff about that.

So I said to the lab,

we're not going to do that because we didn't want to get the wrath from somebody.

But imbendazole, fenbendazole,

I said, why the hell?

People have taken that and you hear people say, well, I got rid of my cancer with this and that.

So I did a dive on it and I said, why parasite medications work against cancer cells?

And it turns out that the parasites use mitochondrial substrate level phosphorylation in the tissue.

And these imbendazole, fenbendazole kill these parasites.

So I tried it on the cancer cell and sure as hell.

It targets the mitochondrial substrate and glycolysis.

So we have a mechanism now why parasite medications are working.

But cancer is not a parasite.

All these people say, oh, cancer is a parasite. It's

not a parasite.

Parasites and tumors use a common metabolic pathway.

And a drug that works against parasites can be very effective against cancer.

And that's what we begin to see, especially under nutritional ketosis.

Right? Can you imagine this?

Yeah.

Oh, sorry. So

ivermectin, it actually works on the mitochondrial cell death pathway, the BCL2 backspat pathway.

So it actually helps push the cell death pathway.